Lowenthal Richard E bought SPRY
January 2, 2026 · Form 4 insider transaction
Lowenthal Richard E bought 875,000 shares of ARS Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
875,000
Price
$0.00
Total value
N/A
InsiderLowenthal Richard E
RoleOfficer, Director, 10% owner
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after875,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2026.